Skip to main content

The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

Publisher: International Union Against Tuberculosis and Lung Disease

More about this publication?
Volume 20, Number 12, 1 December 2016

EDITORIALS

Favourites:
ADD
Favourites:
ADD

ORIGINAL ARTICLES

Policies and practices on the programmatic management of latent tuberculous infection: global survey
pp. 1566-1571(6)
Authors: Hamada, Y.; Sidibe, A.; Matteelli, A.; Dadu, A.; Aziz, M. A.; del Granado, M.; Nishikiori, N.; Floyd, K.; Getahun, H.

Favourites:
ADD

Tuberculosis clinical units improve contact tracing
pp. 1572-1579(8)
Authors: Brugueras, S.; Orcau, À.; Millet, J-P.; Espinosa, L.; de Andrés, A.; Gorrindo, P.; Caylà, J. A.

Favourites:
ADD

Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark
pp. 1580-1587(8)
Authors: Jensen, S. G.; Lillebaek, T.; Wilcke, T.; Pedersen, M. K.; Andersen, P. H. S.; Olsen, N. W.; Seersholm, N.

Favourites:
ADD

Seasonality of tuberculosis in Israel, 2001–2011
pp. 1588-1593(6)
Authors: Margalit, I.; Block, C.; Mor, Z.

Favourites:
ADD

Implication of vitamin D-associated factors in patients with non-tuberculous mycobacterial lung disease
pp. 1594-1602(9)
Authors: Kim, S-Y.; Chang, B.; Jeong, B-H.; Park, H. Y.; Jeon, K.; Shin, S. J.; Koh, W-J.

Favourites:
ADD

Open Access The effect of household poverty on tuberculosis
pp. 1603-1608(6)
Authors: Siroka, A.; Law, I.; Macinko, J.; Floyd, K.; Banda, R. P.; Hoa, N. B.; Tsolmon, B.; Chanda-Kapata, P.; Gasana, M.; Lwinn, T.; Senkoro, M.; Tupasi, T.; Ponce, N. A.

Favourites:
ADD

Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study
pp. 1609-1614(6)
Authors: Mbatchou Ngahane, B. H.; Dahirou, F.; Tchieche, C.; Wandji, A.; Ngnié, C.; Nana-Metchedjin, A.; Nyankiyé, E.; Endale Mangamba, M. L.; Kuaban, C.

Favourites:
ADD

Risk of tuberculosis during pregnancy in Mongolia, a high incidence setting with low HIV prevalence
pp. 1615-1620(6)
Authors: Rendell, N. L.; Batjargal, N.; Jadambaa, N.; Dobler, C. C.

Favourites:
ADD

Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period
pp. 1621-1624(4)
Authors: Bright-Thomas, R. J.; Gondker, A. R.; Morris, J.; Ormerod, L. P.

Favourites:
ADD

Health care provider perspectives on tuberculosis care for foreign-born populations in New York City
pp. 1625-1632(8)
Authors: Zelnick, J. R.; O'Donnell, M. R.; Ahuja, S. D.; Chua, A.; Sullivan Meissner, J.

Favourites:
ADD

Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India
pp. 1633-1638(6)
Authors: Conners, E.; Garfein, R. S.; Rodwell, T. C.; Udwadia, Z. F.; Catanzaro, D. G.

Favourites:
ADD

Utility of the QuantiFERON®-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children
pp. 1639-1646(8)
Authors: El Azbaoui, S.; Sabri, A.; Ouraini, S.; Hassani, A.; Asermouh, A.; Agadr, A.; Abilkassem, R.; Dini, N.; Kmari, M.; Akhaddar, A.; Laktati, Z.; Aieche, S.; El Hafidi, N.; Ben Brahim, F.; Bousfiha, A. A.; Ailal, F.; Deswarte, C.; Schurr, E.; Amar, L.; Bustamante, J.; Boisson-Dupuis, S.; Casanova, J. L.; Abel, L.; El Baghdadi, J.

Favourites:
ADD

IFN-γ promoter polymorphisms do not affect QuantiFERON® TB Gold In-Tube test results in a Canadian population
pp. 1647-1652(6)
Authors: Kiazyk, S.; Larcombe, L.; Lopez, C.; Matyas, S.; Mesa, C.; Orr, P.; Juno, J.; Waruk, J.; Sharma, M.; Ball, T. B.

Favourites:
ADD

Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
pp. 1653-1660(8)
Authors: Singanayagam, A.; Manalan, K.; Connell, D. W.; Chalmers, J. D.; Sridhar, S.; Ritchie, A. I.; Lalvani, A.; Wickremasinghe, M.; Kon, O. M.

Favourites:
ADD

Open Access Evaluation of OMNIgene®•SPUTUM-stabilised sputum for long-term transport and Xpert® MTB/RIF testing in Nepal
pp. 1661-1667(7)
Authors: Maharjan, B.; Kelly-Cirino, C. D.; Weirich, A.; Curry, P. S.; Hoffman, H.; Avsar, K.; Shrestha, B.

Favourites:
ADD

The clinical utility of Xpert® MTB/RIF testing in induced sputum
pp. 1668-1670(3)
Authors: Chew, M. Y.; Ng, J.; Cai, H-M; Lim, T. G.; Lim, T. K.

Favourites:
ADD

Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis
pp. 1671-1676(6)
Authors: Velayutham, B.; Nair, D.; Kannan, T.; Padmapriyadarsini, C.; Sachdeva, K. S.; Bency, J.; Klinton, J. S.; Haldar, S.; Khanna, A.; Jayasankar, S.; Swaminathan, S.

Favourites:
ADD

Pyrazinamide susceptibility testing: proposed new standard with the BACTECTM MGITTM 960 system
pp. 1677-1680(4)
Authors: Piersimoni, C.; Mustazzolu, A.; Iacobino, A.; Giannoni, F.; Santoro, G.; Gherardi, G.; Del Giudice, A.; Perna, R.; Fattorini, L.

Favourites:
ADD

Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins
pp. 1681-1688(8)
Authors: Talavera-Paulín, M.; García-Morales, L.; Ruíz-Sánchez, B. P.; Caamal-Ley, Á. D.; Hernández-Solis, A.; Ramírez-Casanova, E.; Cicero-Sabido, R.; Espitia, C.; Helguera-Repetto, C.; González-y-Merchand, J. A.; Flores-Mejía, R.; Estrada-Parra, S.; Estrada-García, I.; Chacón-Salinas, R.; Wong-Baeza, I.; Serafín-López, J.

Favourites:
ADD

Perception, intention and attempts to quit smoking among Jordanian adolescents from the Irbid Longitudinal Study
pp. 1689-1694(6)
Authors: Jaber, R.; Taleb, Z. B.; Bahelah, R.; Madhivanan, P.; Maziak, W.

Favourites:
ADD

CORRESPONDENCE

Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurements
pp. 1695-1696(2)
Authors: Sturkenboom, Marieke G. G.; Bolhuis, Mathieu S.; Akkerman, Onno W.; de Lange, Wiel C. M.; van der Werf, Tjip S.; Alffenaar, Jan-Willem C.

Favourites:
ADD

In reply 1
pp. 1696-1696(1)
Authors: Mota, Lorena; Al-Efraij, Khalid; Campbell, Jonathon; Cook, Victoria; Lalji, Fawziah Marra; Johnston, James

Favourites:
ADD

In reply 2
pp. 1696-1697(2)
Authors: Maze, M. J.; Paynter, J.; Chiu, W.; Hu, R.; Nisbet, M.; Lewis, C.

Favourites:
ADD

OBITUARY

Stephen Lawn, 1966–2016
pp. 1698-1699(2)
Authors: Harries, Anthony D.; Bekker, Linda-Gail

Favourites:
ADD

VOLUME 20, 2016

Reviewer index
pp. 1700-1702(3)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content